Melinta Therapeutics of New Haven and Eurofarma Laboratórios, one of the largest pharmaceutical companies in Brazil, have entered into commercialization and distribution agreements for delafloxacin, Melinta’s investigational fluoroquinolone. Melinta will receive a combined upfront cash and equity payment of $15 million … more

Trevi Therapeutics of New Haven has received a $15 million loan that will allow it to finish clinical trials on a treatment for chronic itching … more

MannKind Corporation, with facilities in Danbury, announced that Alfred Mann, the company’s founder, has retired as CEO. The company appointed Hakan Edstrom, who is currently President, as the new CEO … more